Compare OPK & INMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OPK | INMD |
|---|---|---|
| Founded | 2006 | 2008 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 921.2M | 842.0M |
| IPO Year | 2011 | 2018 |
| Metric | OPK | INMD |
|---|---|---|
| Price | $1.10 | $14.04 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 3 | 5 |
| Target Price | $1.60 | ★ $17.33 |
| AVG Volume (30 Days) | ★ 2.1M | 712.5K |
| Earning Date | 04-28-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $606,879,000.00 | N/A |
| Revenue This Year | N/A | $1.74 |
| Revenue Next Year | $4.24 | $3.26 |
| P/E Ratio | ★ N/A | $10.11 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.98 | $12.72 |
| 52 Week High | $1.60 | $16.74 |
| Indicator | OPK | INMD |
|---|---|---|
| Relative Strength Index (RSI) | 35.91 | 49.88 |
| Support Level | $0.98 | $14.00 |
| Resistance Level | $1.25 | $14.70 |
| Average True Range (ATR) | 0.04 | 0.31 |
| MACD | -0.01 | -0.04 |
| Stochastic Oscillator | 48.58 | 63.10 |
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF, and Morpheus8, among others. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia, Israel, and other regions.